Ak Pharma Ltd
07343875
Healthy
- 4 outstanding charges (-8)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 29/09/2016
DIRECTOR
SPANISH · UNITED KINGDOM · Age 41
Also on 2 other boards
director · Since 29/09/2016
DIRECTOR
SPANISH · UNITED KINGDOM · Age 46
Also on 2 other boards
Persons with Significant Control
Willand Pharma Ltd
Willand Pharmacy, Linacre House Gables Road, Cullompton, EX15 2PL
Reg: 11037039 · England And Wales · Private Company Limited By Shares
Notified 04/04/2018
Former PSCs
Mr Adis Kikic
Ceased 29/09/2016
Ms Penelope Elizabeth Kikic
Ceased 29/09/2016
Juan Carlos Morillo
Ceased 04/04/2018
Ivan Ferri-Jimenez
Ceased 04/04/2018
Ms Cristina Alonso-Sanchez
Ceased 04/04/2018
Charges4 outstanding
LLOYDS BANK PLC
LLOYDS BANK PLC
LLOYDS BANK PLC
THE ROYAL BANK OF SCOTLAND PLC
CompanyRankvs 1473+ SIC 86900 peers76
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£66k
Balance sheet strength
Cash
£40k
Cash in the bank
Net Current Assets
£355k
Working capital
Current Assets
£499k
Current Liabilities
£144k
Fixed Assets
£3k
Debtors
£413k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 3.47 | -£14k |
| 2024 | 5.18 | +£32k |
| 2023 | 3.43 | -£46k |
| 2022 | 3.21 | +£31k |
| 2021 | 1.81 | — |
Derived from filed accounts. Not audited figures.